BPM
INSY

Bowling Portfolio Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Bowling Portfolio Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-15,612
Closed -$197K – 438
2017
Q2 		$197K Sell
15,612
-46,755
-75% -$553K 0.03% 354
2017
Q1 		$655K Buy
+62,367
New +$665K 0.11% 234

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bowling Portfolio Management's INSY Position: Q3 2017 in Review

Bowling Portfolio Management sold out of Insys Therapeutics, Inc. (INSY) in Q3 2017, closing a stake of 15,612 shares — an estimated $197K sold.

Bowling Portfolio Management first reported a position in INSY in Q1 2017 and held it in 2 quarters. The position peaked at $655K in Q1 2017. 116 funds tracked by Wall St. Rank hold INSY as of Q3 2017.

  • Bowling Portfolio Management reported no remaining Insys Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Bowling Portfolio Management sold 15,612 Insys Therapeutics, Inc. shares in Q3 2017, an estimated $197K.
  • Bowling Portfolio Management first reported a position in Insys Therapeutics, Inc. in Q1 2017 and held it in 2 quarters.
  • Bowling Portfolio Management's Insys Therapeutics, Inc. position peaked at $655K in Q1 2017.
  • 116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2017.

Based on Bowling Portfolio Management's 13F filing for Q3 2017, filed 16 Oct 2017.